Saptarshi Sinha

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Nanomedicine (London, England)

Medical oncology (Northwood, London, England)

Chemistry, an Asian journal

KIIT School of Biotechnology

Bangalore University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KIIT School of Biotechnology Jul 23 2019

India

Senior Research Fellow, Indian Council of Medical Research :: Cancer Biology Division, Dr. C.N Kundu lab

KIIT School of Biotechnology Sep 12 2018 - Mar 31 2019

India

Project Assistant :: Cancer Biology Division, Dr. C.N Kundu lab

Victoria University of Wellington Nov 20 2015 - Nov 30 2016

New Zealand

Research Assistant :: Centre for Biodiscovery, Prof. John Miller lab

Education History

Bangalore University Oct 01 2010 - Jun 01 2013

India

MSC

Bangalore University Aug 01 2006 - Nov 01 2009

India

BSC

Publications

Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Somya Ranjan Dash, Biswajit Das, Chinmay Das, Saptarshi Sinha, Subarno Paul, Rajalaxmi Pradhan, Chanakya Nath Kundu
Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β. Nanomedicine (London, England) (2023)
Saptarshi Sinha, Sefinew Molla, Chanakya Nath Kundu
PARP1-modulated chromatin remodeling is a new target for cancer treatment. Medical oncology (Northwood, London, England) 38 (10) (2021)
Saptarshi Sinha, Chanakya Nath Kundu
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? Medical oncology (Northwood, London, England) 38 (9) (2021)
Jessica J Field, A Jonathan Singh, Saptarshi Sinha, Matthew R Rowe, William Alexander Denny, Darby G Brooke, John Holmes Miller
Synthesis and Microtubule-Destabilizing Activity of N-Cyclopropyl-4-((3,4-dihydroquinolin-1(2H)-yl)sulfonyl)benzamide and its Analogs. Chemistry, an Asian journal 14 (8) (2018)

Saptarshi Sinha.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Saptarshi Sinha